Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
1. Doctors and Patients have filed over 18,000 adverse event reports related to Essure to the FDA and Essure lawsuits are being filed and fought across the U.S. Over half of the FAERS incident reports were filed by women that were required to have invasive surgery to remove the Essure sterilization coils because of severe side-effects. Many women had to undergo full hysterectomies because of the damage done by Essure.
2. Essure carries a Boxed Warning for possible side effects which seems to be slowing demand for Essure, however, everyday Essure is available in the US market puts American women at risk. In September 2015, the FDA held open public hearings in which 43 patients and interested individuals spoke, many giving highly emotional testimony. Most patients asked the FDA to remove the device from the market. The FDA stopped short of removing the device after hearing this testimony, but, instead agreed to further study and required Bayer to include a black box warning on the risk of injury. In addition, all women now considering Essure as a permanent birth control option must receive a “Patient Information Booklet” and sign a Patient-Doctor Discussion Checklist acknowledging that they have been informed of the risks of using the Essure implant.
3. Essure Post-Market Study FDA Requirement Has Been Largely Ignored by Bayer and while Bayer drags its feet, women continue to be injured! The FDA Allowed Essure to Remain on the Market with the requirement that Bayer conduct an additional post-market safety study. The goal of the post-market study was to determine what, if any, further actions related to Essure are needed to protect public health. However, a year and a half after the study was initiated, the study has not yet been provided. Bayer has been dragging its feet on compliance and should be held accountable!
The Bayer post-market study plan was FDA approved on September 2, 2016. The terms of the agreement included the enrollment by Bayer of 2,800 women to be studied over the course of 36 months. Publicly available interim study results are to be published on the FDA website when enrollment hits 500 and then again at enrollment of 1,000 women. Based on an average of signing 77 women each month, these interim study results should have been expected in April 2017 and again in October 2017. As of October 19, 2017, it would be reasonable to expect Bayer to have enrolled just over 1,000 women. However, according to the FDA website, only 136 women have been enrolled, and at this rate it is not likely Bayer will achieve a study of 2,800 women by September 2, 2019.
4. We are not lab rats! Essure has been withdrawn from every other country except the U.S. – Just because the FDA is dragging their feet on a recall, doesn’t mean you shouldn’t demand equal treatment of your health. Help Share this message with women in social media – tell Bayer #WeAreNotLabRats!
5. Congress is demanding answers! Congress is requesting additional information from the FDA regarding why Essure remains on the market while post-market studies are seemingly ignored. On October 20, 2017, Congresswomen Rosa DeLauro (CT-03), Louise Slaughter (NY-25) and Jan Schakowsky (IL-09) sent a letter to FDA Commissioner Scott Gottlieb requesting additional information regarding his decision to allow Essure to remain on the market while the post-market study drags on. According to the Congresswomen, FDA Commissioner should be holding Bayer accountable to the terms of the post-market study and they are requesting a meeting by December 1, 2017
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?